117 related articles for article (PubMed ID: 29384217)
21. Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer.
Xu TP; Wang WY; Ma P; Shuai Y; Zhao K; Wang YF; Li W; Xia R; Chen WM; Zhang EB; Shu YQ
Oncogene; 2018 Sep; 37(36):5020-5036. PubMed ID: 29789713
[TBL] [Abstract][Full Text] [Related]
22. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
Huang M; Huang B; Li G; Zeng S
BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
[TBL] [Abstract][Full Text] [Related]
23. Lysine demethylase LSD1 delivered via small extracellular vesicles promotes gastric cancer cell stemness.
Zhao LJ; Li YY; Zhang YT; Fan QQ; Ren HM; Zhang C; Mardinoglu A; Chen WC; Pang JR; Shen DD; Wang JW; Zhao LF; Zhang JY; Wang ZY; Zheng YC; Liu HM
EMBO Rep; 2021 Aug; 22(8):e50922. PubMed ID: 34060205
[TBL] [Abstract][Full Text] [Related]
24. γ-tocotrienol inhibits the invasion and migration of human gastric cancer cells through downregulation of cyclooxygenase-2 expression.
Zhang YH; Ma K; Liu JR; Wang HX; Tian WX; Tu YH; Sun WG
Oncol Rep; 2018 Aug; 40(2):999-1007. PubMed ID: 29901169
[TBL] [Abstract][Full Text] [Related]
25. Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial.
Li J; Qin S; Xu J; Guo W; Xiong J; Bai Y; Sun G; Yang Y; Wang L; Xu N; Cheng Y; Wang Z; Zheng L; Tao M; Zhu X; Ji D; Liu X; Yu H
J Clin Oncol; 2013 Sep; 31(26):3219-25. PubMed ID: 23918952
[TBL] [Abstract][Full Text] [Related]
26. YWHAE silencing induces cell proliferation, invasion and migration through the up-regulation of CDC25B and MYC in gastric cancer cells: new insights about YWHAE role in the tumor development and metastasis process.
Leal MF; Ribeiro HF; Rey JA; Pinto GR; Smith MC; Moreira-Nunes CA; Assumpção PP; Lamarão LM; Calcagno DQ; Montenegro RC; Burbano RR
Oncotarget; 2016 Dec; 7(51):85393-85410. PubMed ID: 27863420
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic regulation of epithelial to mesenchymal transition by the Lysine-specific demethylase LSD1/KDM1A.
Ambrosio S; Saccà CD; Majello B
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):905-910. PubMed ID: 28720390
[TBL] [Abstract][Full Text] [Related]
28. Anti-Tumor Effects of Vitamin B2, B6 and B9 in Promonocytic Lymphoma Cells.
Mikkelsen K; Prakash MD; Kuol N; Nurgali K; Stojanovska L; Apostolopoulos V
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31374832
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
[TBL] [Abstract][Full Text] [Related]
30. LPE-1, an orally active pyrimidine derivative, inhibits growth and mobility of human esophageal cancers by targeting LSD1.
Wang B; Zhao B; Pang LP; Zhao YD; Guo Q; Wang JW; Zheng YC; Zhang XH; Liu Y; Liu GY; Guo WG; Wang C; Li ZH; Mao XJ; Yu B; Ma LY; Liu HM
Pharmacol Res; 2017 Aug; 122():66-77. PubMed ID: 28571892
[TBL] [Abstract][Full Text] [Related]
31. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
32. DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer.
Teng F; Xu Z; Chen J; Zheng G; Zheng G; Lv H; Wang Y; Wang L; Cheng X
Oncol Rep; 2018 Sep; 40(3):1203-1222. PubMed ID: 29956792
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
Li X; Li T; Chen D; Zhang P; Song Y; Zhu H; Xiao Y; Xing Y
Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764
[TBL] [Abstract][Full Text] [Related]
34. CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1.
Lynch JT; Cockerill MJ; Hitchin JR; Wiseman DH; Somervaille TC
Anal Biochem; 2013 Nov; 442(1):104-6. PubMed ID: 23911524
[TBL] [Abstract][Full Text] [Related]
35. The histone demethylase LSD1 is required for estrogen-dependent S100A7 gene expression in human breast cancer cells.
Yu SE; Jang YK
Biochem Biophys Res Commun; 2012 Oct; 427(2):336-42. PubMed ID: 23000163
[TBL] [Abstract][Full Text] [Related]
36. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
Zheng B; Ren T; Huang Y; Guo W
Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
[TBL] [Abstract][Full Text] [Related]
37. Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric Cancer.
Huang M; Hou J; Wang Y; Xie M; Wei C; Nie F; Wang Z; Sun M
Mol Ther; 2017 Apr; 25(4):1014-1026. PubMed ID: 28214253
[TBL] [Abstract][Full Text] [Related]
38. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
Zhang X; Zhang X; Yu B; Hu R; Hao L
Biochimie; 2017 Jun; 137():12-19. PubMed ID: 28223039
[TBL] [Abstract][Full Text] [Related]
39. Apatinib for the treatment of gastric cancer.
Roviello G; Ravelli A; Fiaschi AI; Cappelletti MR; Gobbi A; Senti C; Zanotti L; Polom K; Reynolds AR; Fox SB; Generali D
Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):887-92. PubMed ID: 27376400
[TBL] [Abstract][Full Text] [Related]
40. Histone demethylase JMJD2B-mediated cell proliferation regulated by hypoxia and radiation in gastric cancer cell.
Kim JG; Yi JM; Park SJ; Kim JS; Son TG; Yang K; Yoo MA; Heo K
Biochim Biophys Acta; 2012; 1819(11-12):1200-7. PubMed ID: 23046878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
